AcuFocus, Inc.
12
0
0
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
36%
4 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Clinical Investigation of a Small Aperture Extended Depth of Focus Intraocular Lens in Patients With Complex Corneas
Role: lead
Post-approval Follow-up Study of the IC-8 Apthera Intraocular Lens (IOL)
Role: lead
Evaluation of Visual Outcomes in Patients With Complex Corneas Implanted With the IC-8 IOL
Role: lead
IOL Implantation After KAMRA Inlay Removal
Role: lead
Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens
Role: lead
Evaluation of Long-Term Clinical Acceptability and Satisfaction With the IC-8 Intraocular Lens
Role: lead
Qualitative Validation of Patient-Reported Outcomes (PRO) Instrument
Role: lead
Post-Approval Study With the KAMRA Inlay
Role: lead
Safety and Effectiveness Study of the AcuFocus Corneal Inlay ACI 7000PDT in Presbyopes
Role: lead
Safety and Effectiveness Study of the AcuFocus Corneal Inlay ACI 7000PDT in Presbyopes
Role: lead
A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A
Role: lead
Safety and Effectiveness of the AcuFocus Corneal Inlay ACI7000PDT in Presbyopes
Role: lead
All 12 trials loaded